MedPath

Neomycin and Polymyxin B Sulfates and Dexamethasone

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment USP STERILE Rx Only

Approved
Approval ID

d92683cc-b6e0-4e52-aefa-990f3369b4dc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 24, 2019

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neomycin, Polymyxin B Sulfates, Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-0571
Application NumberANDA062938
Product Classification
M
Marketing Category
C73584
G
Generic Name
Neomycin, Polymyxin B Sulfates, Dexamethasone
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMarch 1, 2018
FDA Product Classification

INGREDIENTS (5)

DEXAMETHASONEActive
Quantity: 1 mg in 1 g
Code: 7S5I7G3JQL
Classification: ACTIB
POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 g
Code: 19371312D4
Classification: ACTIM
NEOMYCIN SULFATEActive
Quantity: 3.5 mg in 1 g
Code: 057Y626693
Classification: ACTIM
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Neomycin and Polymyxin B Sulfates and Dexamethasone - FDA Drug Approval Details